Literature DB >> 19390212

Overweight, obesity and chronic kidney disease.

Stephen M S Ting1, Harikrishnan Nair, Irene Ching, Shahrad Taheri, Indranil Dasgupta.   

Abstract

The sharp rise in the prevalence of chronic kidney disease (CKD) that parallels an increase in the prevalence of obesity in the recent years is a cause for great concern. CKD increases the rate of cardiovascular disease (CVD), development of end-stage renal disease, and leads to premature death. Although no direct causality link between obesity and CKD can yet be established, this appears highly likely. CKD should be regarded as a major complication of overweight and obesity, regardless of whether the association was independent or through the influence of diabetes, hypertension, CVD, metabolic syndrome and high fructose intake. We review the literature on the complex but positive association between obesity and CKD, the pathological effect of excess adiposity in kidney injury and the potential role of weight reduction therapy in reducing the burden of CKD. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19390212     DOI: 10.1159/000214206

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  26 in total

Review 1.  Early life obesity and chronic kidney disease in later life.

Authors:  Hyung Eun Yim; Kee Hwan Yoo
Journal:  Pediatr Nephrol       Date:  2014-08-22       Impact factor: 3.714

2.  Erythropoietin has a restorative effect on the contractility of arteries following experimental hypoxia.

Authors:  Sarah B Withers; Neha Passi; Alfred S Williams; Declan de Freitas; Anthony M Heagerty
Journal:  J Cardiovasc Dis Res       Date:  2013-10-16

3.  Laparoscopic sleeve gastrectomy prevents the deterioration of renal function in morbidly obese patients over 40 years.

Authors:  Jaime Ruiz-Tovar; Lorena Giner; Felipe Sarro-Sobrin; Maria Engracia Alsina; María Paz Marco; Lourdes Craver
Journal:  Obes Surg       Date:  2015-05       Impact factor: 4.129

4.  Evaluation of a method for fibroblast growth factor-23: a novel biomarker of adverse outcomes in patients with renal disease.

Authors:  Sridevi Devaraj; Catherine Duncan-Staley; Ishwarlal Jialal
Journal:  Metab Syndr Relat Disord       Date:  2010-08-13       Impact factor: 1.894

Review 5.  Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus.

Authors:  George L Bakris
Journal:  Mayo Clin Proc       Date:  2011-05       Impact factor: 7.616

6.  The effect of biliopancreatic diversion surgery on renal function--a retrospective study.

Authors:  Biju Jose; Stephen Ford; Paul Super; G Neil Thomas; Indranil Dasgupta; Shahrad Taheri
Journal:  Obes Surg       Date:  2013-05       Impact factor: 4.129

7.  Obesity, Acute Kidney Injury, and Mortality in Critical Illness.

Authors:  John Danziger; Ken P Chen; Joon Lee; Mengling Feng; Roger G Mark; Leo Anthony Celi; Kenneth J Mukamal
Journal:  Crit Care Med       Date:  2016-02       Impact factor: 7.598

Review 8.  Prevention of overweight and obesity: how effective is the current public health approach.

Authors:  Ruth S M Chan; Jean Woo
Journal:  Int J Environ Res Public Health       Date:  2010-02-26       Impact factor: 3.390

9.  Do Obese Individuals With Hypertension Have More Difficult-to-Control Blood Pressure and End Organ Damage Than Their Nonobese Counterparts?

Authors:  Mark David Jesky; Manvir Kaur Hayer; Mark Thomas; Indranil Dasgupta
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-23       Impact factor: 3.738

Review 10.  Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications.

Authors:  José M López-Novoa; Ana B Rodríguez-Peña; Alberto Ortiz; Carlos Martínez-Salgado; Francisco J López Hernández
Journal:  J Transl Med       Date:  2011-01-20       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.